Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Vaccine

• Publication date

  1998-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(97)00301-0PMID 9682344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cleavability of hemagglutinin determines spread of avian influenza viruses in the chorioallantoic membrane of chicken embryo

  2005cited by this paper
• Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996).

  1997cited by this paper
• Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load.

  1997cited by this paper
• African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses

  1996cited by this paper
• Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity

  1995cited by this paper
• Egg fluids and cells of the chorioallantoic membrane of embryonated chicken eggs can select different variants of influenza A (H3N2) viruses.

  1995cited by this paper
• Abortive infection of Vero cells by an influenza A virus (FPV).

  1995cited by this paper
• Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting.

  1995cited by this paper
• Pandemic influenza (un)preparedness described

  1995cited by this paper
• Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero).

  1995cited by this paper
• Clinical influenza virus and the embryonated Hen's egg

  1993cited by this paper
• Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin‐like endoprotease.

  1992cited by this paper
• Absence of viral sequences in the WHO-Vero Cell Bank. A collaborative study.

  1992cited by this paper
• Regulatory philosophy and acceptability of cells for the production of biologicals.

  1991cited by this paper
• Qualification of working cell banks for the Vero cell line to produce licensed human vaccines.

  1989cited by this paper
• Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.

  1989cited by this paper
• Vero cells : origin, properties and biomedical applications

  1988cited by this paper
• Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK).

  1987cited by this paper
• Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus.

  1987cited by this paper
• Host cell-mediated variation in H3N2 influenza viruses.

  1987cited by this paper
• Tumorigenicity of Vero cells.

  1984cited by this paper
• Evidence for host-cell selection of influenza virus antigenic variants

  1983cited by this paper
• Protein synthesis in Vero cells abortively infected with influenza B virus.

  1981cited by this paper
• An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines.

  1977cited by this paper
• Activation of influenza A viruses by trypsin treatment.

  1975cited by this paper
• Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide.

  1975cited by this paper
• Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

  1973cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Reverse genetic rescue and propagation of human influenza A(H3N2) master virus seed in HEK-293 suspension cells.

  2026cites this paper
• Optimization for the production of a dengue live-attenuated Quadrivalent vaccine in Vero cells grown on microcarriers

  2025cites this paper
• Attenuation and altered replication of IBV strain tl/CH/LDT3/03 after serial passage in chicken embryo fibroblasts and Vero cells

  2025cites this paper
• Vaccine Induced Autoimmunity May Cause Autism and Neurological Disorders

  2025cites this paper
• Optimal paraformaldehyde levels for disinfection of eggs used in vaccine production

  2024cites this paper
• Seed Train Optimization in Microcarrier-Based Cell Culture Post In Situ Cell Detachment through Scale-Down Hybrid Modeling

  2024cites this paper
• Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection

  2024cites this paper
• An avian-origin internal backbone effectively increases the H5 subtype avian influenza vaccine candidate yield in both chicken embryonated eggs and MDCK cells

  2024cites this paper
• The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge

  2024cites this paper
• Reduction in Interferon-Stimulated Genes Contributes to High-Yield Production of Influenza Virus in Suspension MDCK Cells

  2024cites this paper
• Examination of the cross-reactivity between vaccinia virus Tiantan strain and monkeypox virus.

  2023cites this paper
• DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action

  2023cites this paper
• In Vitro Anti-Influenza A Virus H1N1 Effect of Sesquiterpene-Rich Extracts of Carpesium abrotanoides

  2022cites this paper
• Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort

  2022cites this paper
• Recent advances and current challenges in process intensification of cell culture‐based influenza virus vaccine manufacturing

  2021cites this paper
• Influenza vaccines: Past, present, and future

  2021cites this paper
• Adjuvant Activity of Vero Cell on Cellular and Humoral Immunity Responses against E. coli O157:H7 Infections in Balb/c Mice

  2021cites this paper
• Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study

  2020cites this paper
• Engineering a Model to Study Viral Infections: Bioprinting, Microfluidics, and Organoids to Defeat Coronavirus Disease 2019 (COVID-19)

  2020cites this paper
• Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform.

  2020cites this paper
• Vero cell upstream bioprocess development for the production of viral vectors and vaccines

  2020cites this paper
• Generation and Characterization of Dual-Fluorescent Influenza Virus-like Particles (VLPs) in Insect Cells

  2019cites this paper
• Titre : Title : Metabolic and Kinetic analyses of influenza production in perfusion HEK 293 cell culture Auteurs :

  2019cites this paper
• Challenges in the development of egg-independent vaccines for influenza

  2019cites this paper
• Preparation and evaluation of a novel, live, attenuated influenza H1N1 vaccine strain produced by a modified classical reassortment method

  2018cites this paper
• Recombinant infectious bronchitis viruses expressing heterologous S1 subunits: potential for a new generation of vaccines that replicate in Vero cells.

  2018cites this paper
• The S2 Subunit of Infectious Bronchitis Virus Beaudette Is a Determinant of Cellular Tropism

  2018cites this paper
• The evolution of seasonal influenza viruses

  2017cites this paper
• Egg-Independent Influenza Vaccines and Vaccine Candidates

  2017cites this paper
• A Systems Approach to Studying the Differentiation of Stem Cells Towards Hepatocytes

  2017cites this paper
• Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus.

  2017cites this paper
• Alternative reverse genetics system for influenza viruses based on a synthesized swine 45S rRNA promoter

  2017cites this paper
• A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells

  2017cites this paper
• Murine polyomavirus VLPs as a platform for cytotoxic T cell epitope-based influenza vaccine candidates

  2016cites this paper
• Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production

  2016cites this paper
• Attenuated Strains of Salmonella enterica Serovars Typhi and Paratyphi as Live Oral Vaccines Against Enteric Fever

  2016cites this paper
• The establishment and characteristics of cell-adapted IBV strain H120

  2016cites this paper
• Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

  2016cites this paper
• Formulation and Manufacturing

  2016cites this paper
• Advances in the development of influenza virus vaccines

  2015cites this paper
• Development of high-yield influenza A virus vaccine viruses

  2015cites this paper
• Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

  2015cites this paper
• A single NS2 mutation of K86R promotes PR8 vaccine donor virus growth in Vero cells.

  2015cites this paper
• A Single Mutation at PB1 Residue 319 Dramatically Increases the Safety of PR8 Live Attenuated Influenza Vaccine in a Murine Model without Compromising Vaccine Efficacy

  2015cites this paper
• Analysis of Influenza Vaccines

  2015cites this paper
• Design of alternative live attenuated influenza virus vaccines.

  2015cites this paper
• Cell culture-based influenza vaccines: A necessary and indispensable investment for the future

  2015cites this paper
• Establishment of MDCK Stable Cell Lines Expressing TMPRSS2 and MSPL and Their Applications in Propagating Influenza Vaccine Viruses in Absence of Exogenous Trypsin

  2015cites this paper
• An A14U Substitution in the 3′ Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs

  2015cites this paper
• Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.

  2015cites this paper
• Advancements in the development of subunit influenza vaccines.

  2015cites this paper
• A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.

  2015cites this paper
• Considerations for the rapid deployment of vaccines against H7N9 influenza

  2014cites this paper
• Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation

  2014cites this paper
• Superior In Vitro Stimulation of Human CD8+ T-Cells by Whole Virus versus Split Virus Influenza Vaccines

  2014cites this paper
• Seasonal influenza vaccination and technologies

  2014cites this paper
• Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing

  2014cites this paper
• An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.

  2014cites this paper
• All-in-One Bacmids: an Efficient Reverse Genetics Strategy for Influenza A Virus Vaccines

  2014cites this paper
• Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography.

  2014cites this paper
• Viral Vaccines Purification

  2014cites this paper
• Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.

  2014cites this paper
• Tetrahymena thermophila: An expression platform for the production of viral antigens

  2014cites this paper
• Micro-scale vaccine bioprocessing of a Japanese Encephalitis Virus vaccine

  2014cites this paper
• Influenza Cell-Culture Vaccine Production

  2014cites this paper
• 2 Production of LAIV Vaccines 2 . 1 Alternative Strategies to Generate Influenza Virus Vaccines

  2014cites this paper
• High Yield Production of Influenza Virus in Madin Darby Canine Kidney (MDCK) Cells with Stable Knockdown of IRF7

  2013cites this paper
• Determining Influenza Virus Shedding at Different Time Points in Madin-Darby Canine Kidney Cell Line

  2013cites this paper
• Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development

  2013cites this paper
• Impact of cultivation conditions on N‐glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture

  2013cites this paper
• Reconstruction of H3N2 influenza virus based virosome in-vitro

  2013cites this paper
• Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines

  2013cites this paper
• Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production.

  2013influential citation
• Cell Culture-based Influenza Vaccines as Alternatives to Egg-based Vaccines

  2013cites this paper
• Quantitation of influenza virus using field flow fractionation and multi-angle light scattering for quantifying influenza A particles.

  2013cites this paper
• Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination

  2013cites this paper
• Development of a Production Process for a Virus Like Particle Based Vaccine in Cell Culture

  2013cites this paper
• An MDCK Cell Culture-Derived Formalin-Inactivated Influenza Virus Whole-Virion Vaccine from an Influenza Virus Library Confers Cross-Protective Immunity by Intranasal Administration in Mice

  2013cites this paper
• Accelerated Biopharmaceutical Development: Vero Cell Technology and Pandemic Influenza Vaccine Production

  2013cites this paper
• A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]

  2012cites this paper
• MDCK cell-cultured influenza virus vaccine protects mice from lethal challenge with different influenza viruses

  2012cites this paper
• Old and new ways to combat human influenza virus

  2012cites this paper
• Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons

  2012cites this paper
• Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine

  2012cites this paper
• Transient Expression of Hemagglutinin Antigen from Low Pathogenic Avian Influenza A (H7N7) in Nicotiana benthamiana

  2012cites this paper
• Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine.

  2012cites this paper
• Current cell-based influenza vaccine production technology as pandemic contingency

  2012cites this paper
• Cell culture based production of avian influenza vaccines

  2012cites this paper
• Intranasal Administration of Influenza Vaccines

  2012cites this paper
• A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies.

  2012cites this paper
• Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes

  2012cites this paper
• New Strategies for the Development of H5N1 Subtype Influenza Vaccines

  2012cites this paper
• Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.

  2012cites this paper
• Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.

  2012cites this paper
• Monitoring of Host-Cell Infection and Virus-Induced Apoptosis in Influenza Vaccine Production

  2012cites this paper
• A/H5N1 Prepandemic Influenza Vaccine (Vepacel®): A Guide to Its Use

  2012cites this paper
• Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens

  2012cites this paper
• Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production

  2012cites this paper
• Cell-Based Influenza Vaccines

  2012cites this paper
• Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.

  2011cites this paper